Febuxostat

98%

  • Product Code: 55064
  CAS:    144060-53-7
Molecular Weight: 316.37 g./mol Molecular Formula: C₁₆H₁₆N₂O₃S
EC Number: MDL Number:
Melting Point: 238-239°C Boiling Point: 536.6°C
Density: Storage Condition: 2-8°C
Product Description: Febuxostat is primarily used in the treatment of chronic hyperuricemia in patients with gout. It works by inhibiting the enzyme xanthine oxidase, which plays a key role in the production of uric acid. By reducing uric acid levels in the blood, it helps prevent the formation of urate crystals that cause gout symptoms such as joint pain, inflammation, and swelling. It is particularly prescribed for patients who cannot tolerate or have not responded well to allopurinol, another common medication for gout. Febuxostat is also used in managing conditions associated with elevated uric acid levels, such as kidney stones or tumor lysis syndrome. It is typically taken orally and requires regular monitoring of uric acid levels to ensure effective treatment and minimize potential side effects.
Product Specification:
Test Specification
Purity 98-100
APPEARANCE White to Off-white Powder to Crystal
Infrared spectrum Conforms to Structure
NMR Conforms to Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.250 10-20 days €7.91
+
-
1.000 10-20 days €10.29
+
-
5.000 10-20 days €21.90
+
-
25.000 10-20 days €78.09
+
-
100.000 10-20 days €258.02
+
-
Febuxostat
Febuxostat is primarily used in the treatment of chronic hyperuricemia in patients with gout. It works by inhibiting the enzyme xanthine oxidase, which plays a key role in the production of uric acid. By reducing uric acid levels in the blood, it helps prevent the formation of urate crystals that cause gout symptoms such as joint pain, inflammation, and swelling. It is particularly prescribed for patients who cannot tolerate or have not responded well to allopurinol, another common medication for gout. Febuxostat is also used in managing conditions associated with elevated uric acid levels, such as kidney stones or tumor lysis syndrome. It is typically taken orally and requires regular monitoring of uric acid levels to ensure effective treatment and minimize potential side effects.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :

The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page